Minutes of the Extraordinary General Meeting (the “Meeting”) of IGEA Pharma N.V., a public limited company (in Dutch: naamloze vennootschap), having its statutory seat in Amsterdam, the Netherlands, and its registered office address at Siriusdreef 17, 2132WT Hoofddorp, the Netherlands, registered with the Trade Register of the Dutch Chamber of Commerce under number: 70212821 (the “Company”), held physically at Gustav Mahlerlaan 308, 1082ME Amsterdam, the Netherlands on 11 November 2023 at 14:05 hours CET.
Ad hoc announcement pursuant to article 53 LR
IGEA announces annual General Meeting Resolutions
Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) announced the annual General Meeting Resolution.
Hoofddorp, the Netherlands, 13 November 2023. IGEA Pharma N.V. (SIX: IGPH) today announced that the Annual General Meeting approved all the agenda resolutions. The minutes of the meeting are available at igeapharma.nl/category/information-for-shareholders
IGEA to update on RBCARE business combination
Microsoft Word – 20231009 igea_press release
FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, AUSTRALIA, CANADA, OR JAPAN
IGEA and RBCARE2023 signed to combine their businesses
FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT
FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION
IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES,
AUSTRALIA, CANADA, OR JAPAN
IGEA discloses its half-year figures 2023
Hoofddorp, the Netherlands, 30 September2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its unaudited interim financial statements as of 30 June 2023.
Convening notice
Dear Shareholder,
The board of directors (the “Board”) of IGEA Pharma N.V. (the “Company”) hereby
invites you to attend the Annual General Meeting on 09.11.2023 (the “AGM”) that will take
place at Tribes Amsterdam South Axis FOZ, Gustav Mahlerlaan 308, 1082 ME Amsterdam,
the Netherlands. The meeting will start at 14:00 hours CEST and is to be attended physically.
Registration will start at 13:00 hours CEST.
IGEA filed the appeal on SIX decision of delisting
Hoofddorp, the Netherlands, 30 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the filing of the appeal to the decision of the SIX to delist the company.
IGEA to update on SIX decision
Hoofddorp, the Netherlands, 4 August 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the intention to appeal the decision of the SIX to delist the company.
IGEA discloses its Annual Report 2022
Hoofddorp, the Netherlands, 30 July 2023. IGEA Pharma N.V. (SIX: IGPH) announced the disclosure if its Annual Report 2022.
IGEA to apply for a further extension of its disclosure obligations
Hoofddorp, the Netherlands, 31 May 2023. IGEA Pharma N.V. (SIX: IGPH) today announced the
submission of a further exemption application to the SIX.